IO Biotech, Inc.
IOBT
$0.98
-$0.04-3.92%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 23.69M | 24.31M | 23.81M | 23.48M | 23.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 95.18M | 96.42M | 93.40M | 93.72M | 91.44M |
| Operating Income | -95.18M | -96.42M | -93.40M | -93.72M | -91.44M |
| Income Before Tax | -94.05M | -88.99M | -87.30M | -87.64M | -85.23M |
| Income Tax Expenses | 1.44M | 1.35M | 703.00K | 861.00K | 852.00K |
| Earnings from Continuing Operations | -95.49 | -90.34 | -88.00 | -88.50 | -86.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -95.49M | -90.34M | -88.00M | -88.50M | -86.08M |
| EBIT | -95.18M | -96.42M | -93.40M | -93.72M | -91.44M |
| EBITDA | -94.92M | -96.17M | -93.16M | -93.49M | -91.23M |
| EPS Basic | -1.45 | -1.37 | -1.44 | -1.86 | -2.16 |
| Normalized Basic EPS | -0.89 | -0.84 | -0.89 | -1.15 | -1.33 |
| EPS Diluted | -1.45 | -1.37 | -1.44 | -1.86 | -2.16 |
| Normalized Diluted EPS | -0.89 | -0.84 | -0.89 | -1.15 | -1.33 |
| Average Basic Shares Outstanding | 263.52M | 263.52M | 247.81M | 210.75M | 173.68M |
| Average Diluted Shares Outstanding | 263.52M | 263.52M | 247.81M | 210.75M | 173.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |